Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
J Pediatr Gastroenterol Nutr ; 78(2): 211-216, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38374573

RESUMEN

BACKGROUND: Food protein-induced allergic proctocolitis (FPIAP) is a nonimmunoglobulin (IgE)-mediated food hypersensitivity and the exact mechanisms that cause FPIAP are unknown. Chemokines play crucial roles in the development of allergic diseases. OBJECTIVE: To examine serum levels of a group of chemokines in infants with FPIAP. METHODS: In 67 infants with FPIAP and 65 healthy infants, we measured serum levels of mucosa-associated epithelial chemokine (MEC/CCL28), thymus-expressed chemokine (TECK/CCL25), CX3CL1 and macrophage inflammatory protein (MIP)-3a/CCL20. RESULTS: Infants with FPIAP had a lower median value of MIP3a/CCL20 than healthy infants [0.7 (0-222) vs. 4 (0-249) pg/mL, respectively] (p < 0.001). Infants with MIP3a/CCL20 levels ≤0.95 pg/mL have 13.93 times more risk of developing FPIAP than infants with MIP3a/CCL20 levels >0.95 pg/mL. Serum MEC/CCL28, TECK/CCL25, and CX3CL1 levels were similar between the infants with FPIAP and the control group. CONCLUSION: MIP3a/CCL20 serum levels were reduced in infants with FPIAP compared with healthy controls. Whether this finding has a role in pathogenesis remains to be determined.


Asunto(s)
Quimiocina CCL20 , Hipersensibilidad a los Alimentos , Proctocolitis , Humanos , Lactante , Hipersensibilidad a los Alimentos/complicaciones , Proteínas Inflamatorias de Macrófagos , Membrana Mucosa , Quimiocina CCL20/sangre , Quimiocina CCL20/química
2.
Indian J Dermatol ; 67(3): 312, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36386107

RESUMEN

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease. Skin and gut are the organs that first encounter antigens and environmental triggers. The mechanisms behind the relation between skin and gut immune responses in AD have not been identified yet. Aims and Objectives: To investigate mucosa-associated epithelial chemokine (MEC/CCL28), thymus-expressed chemokine (TECK/CCL25), periostin and zonulin levels in infants with AD. Materials and Methods: Children under one year old participated in the study. We used a propensity matching score. We included 39 infants who had active AD lesions at the time of evaluation. Serum MEC/CCL28, TECK/CCL25, periostin and zonulin levels were measured. Results: We examined age and sex matched 39 infants with AD and 39 healthy infants. Median value of zonulin was lower in infants with AD [49.2 (27.1-71.8) ng/mL] compared to healthy controls [58.5 (27.3-80.8) ng/mL] (P < 0.001). Infants with zonulin levels ≤55.15 ng/mL had 11.64 times more risk of developing AD than the infants with zonulin levels >55.15 ng/mL. Infants whose MEC/CCL28 levels were ≥8.3 ng/mL had 5.83 times more risk of developing AD than the infants with MEC levels <8.3 ng/mL. Duration of AD and SCORAD index score did not show correlation with MEC/CCL28, TECK/CCL25, periostin and zonulin levels. Conclusion: Low zonulin levels and high MEC/CCL28 levels in infants may show an increased association with AD.

4.
Indian J Pediatr ; 83(8): 777-82, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26821547

RESUMEN

OBJECTIVES: To evaluate serum vitamin D levels in cases of recurrent respiratory infections and chronic cough and to investigate the effect of vitamin D therapy on recurrence of the diseases. METHODS: This prospective observational study was performed by comparing serum vitamin D levels in children with recurrent respiratory infections, chronic cough and healthy children. One-hundred-one children with chronic cough, ninety-eight children with recurrent respiratory infections and one-hundred-twenty-four healthy children were enrolled in the study. A structured questionnaire was completed to collect data on demography, diet, duration of breastfeeding, vitamin D supplementation and family history for allergic diseases. In patients with low serum vitamin D levels (<20 ng/ml), vitamin D therapy was administered in addition to conventional treatment for the diseases. Patients were followed up for 6 mo and their complaints were evaluated. RESULTS: Mean serum 25(OH) vitamin D level in the recurrent respiratory infections group was 11.97 ± 4.04 ng/ml, chronic cough group was 13.76 ± 4.81 ng/ml and control group was 31.91 ± 18.79 ng/ml. Comparison of serum 25(OH) vitamin D levels between the study groups revealed a statistically significant difference (p < 0.05). 25(OH)D deficiency in children was associated with increased frequency of recurrent respiratory infections and chronic cough. CONCLUSIONS: To conclude, administration of supplementary vitamin D may be useful in the treatment and preventation of recurrent respiratory infections and chronic cough.


Asunto(s)
Tos/congénito , Infecciones del Sistema Respiratorio/complicaciones , Deficiencia de Vitamina D/complicaciones , Niño , Preescolar , Femenino , Humanos , Masculino , Estudios Prospectivos , Vitamina D
6.
Allergy Asthma Proc ; 35(6): 482-8, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25584916

RESUMEN

Asthma is characterized by chronic airway inflammation that is associated with structural changes termed airway remodeling. Recently, cytokines/mediators that augment inflammation have been attracting attention in this field. The aim of this study was to evaluate serum angiopoietin (Ang)-1, Ang-2, vascular endothelial growth factor (VEGF), and tumor necrosis factor (TNF) alpha values, which have important roles in inflammation, angiogenesis, and remodeling in asthmatic children. We also documented correlations between demographic features, duration of asthma, and pulmonary function test (PFT) parameters. Randomly selected 40 children (20 male and 20 female children, aged 6-16 years) with mild or moderate persistent asthma and 32 healthy children (15 male and 17 female children, aged 6-16 years) enrolled in the study. All asthmatic children had been using inhaled corticosteroids at least for the last 3 months. Serum Ang-1 levels were significantly lower in asthmatic children than those in normal controls. The Ang-1/Ang-2 ratio was also significantly lower in asthmatic children compared with those in normal controls (p < 0.01). However, serum Ang-2, VEGF, and TNF-alpha levels were similar in the two groups. A significant positive correlation was found between VEGF and duration of asthma. No correlation between serum Ang-1, Ang-2, VEGF values, and PFT parameters was obtained. On the other hand, significant negative correlation was detected between serum TNF-alpha and forced expiratory volume in 1 second. We have shown that serum Ang-1 levels and Ang-1/Ang-2 ratio were significantly reduced and balance was toward Ang-2 in asthmatics children. This process may lead to inflammation, destabilization of blood vessels, and trigger remodeling.


Asunto(s)
Angiopoyetina 1/sangre , Angiopoyetina 2/sangre , Asma/sangre , Factor de Necrosis Tumoral alfa/sangre , Factor A de Crecimiento Endotelial Vascular/sangre , Asma/diagnóstico , Estudios de Casos y Controles , Niño , Femenino , Humanos , Masculino , Pruebas de Función Respiratoria , Índice de Severidad de la Enfermedad
7.
Pediatr Allergy Immunol ; 20(8): 741-7, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19239659

RESUMEN

Food allergy has been increasingly reported in children who had orthotopic liver transplantation (OLT). We aimed to conduct a prospective study to investigate the prevalence of sensitizations and food allergy in pediatric OLT recipients. We also aimed to identify potential risk factors. The study group consisted of 28 children (14 male, 14 female, mean age 4.96 +/- 0.76 yrs) who had OLT. Total eosinophil count (TEC), total IgE, and specific IgEs were studied before and 3, 6, 12 months after OLT. Six patients (21%) developed multiple food allergies. Mean age of six patients at OLT who developed food allergy was younger compared to the non-food allergy group (10.2 months vs. 68.9 months, p < 0.05). Food allergy has been developed within 1 yr in 5, and in 20 months in one patient after OLT. All six patients had cow's milk and egg allergy after OLT. Five children developed wheat, one children developed lentil and another one developed peach allergy in addition to cow's milk and egg allergy. Out of six food-allergic patients after OLT, four children developed Epstein-Barr virus (EBV) infection prior to food allergy. Before OLT, TECs and total IgE levels were not differed among food allergic and non-food allergic patients (p > 0.05). Mean of TECs were significantly higher in food allergic group compared to non-food allergic group at each time point after OLT (p < 0.05). Though statistically insignificant, mean of total IgE levels were also higher in the food allergic group (p > 0.05). These findings suggest that food allergy should be considered after OLT in patients who are younger than 1 yr of age, who developed hypereosinophilia, high total IgE levels or EBV viremia.


Asunto(s)
Hipersensibilidad a los Alimentos/epidemiología , Trasplante de Hígado/efectos adversos , Factores de Edad , Antígenos Virales/sangre , Preescolar , Hipersensibilidad al Huevo/epidemiología , Eosinofilia , Femenino , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Inmunoglobulina E/sangre , Masculino , Hipersensibilidad a la Leche/epidemiología , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Carga Viral
8.
Allergy Asthma Proc ; 30(1): 41-6, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19063817

RESUMEN

Plasminogen activator inhibitor (PAI-1) has an essential role in tissue remodeling after inflammation. Recent literature revealed only one study evaluating PAI-1 4G/5G gene polymorphism in children with asthma and none in children with allergic rhinitis. We aimed to investigate distribution of PAI-1 4G/5G polymorphism in a group of Turkish children with asthma and allergic rhinitis and compare these findings with those obtained in normal peers. Patients with physician-diagnosed asthma (n = 106) and allergic rhinitis (n = 99) and 83 healthy peers were included in this study. We evaluated PAI-1 4G/5G polymorphism genotype as well as the possible association between PAI-1 4G/5G polymorphism and pulmonary function tests, serum total immunoglobulin E (IgE), total eosinophil count, and skin-prick test positivity in our study. The prevalence of the 4G allele significantly exceeded the values found in the controls both in patients with asthma (p = 0.001) and in patients with allergic rhinitis (p = 0.002). Interestingly, comparison of asthmatic patients revealed that mean baseline percent forced expiratory volume in 1 second and forced vital capacity were significantly higher in patients who bear 5G/5G genotype than in those who have 4G/4G or 4G/5G genotypes. No statistically significant relationship were found between PAI-1 polymorphism and total serum IgE levels, total eosinophil count, or selected skin test responses to aeroallergens. Our study suggests that Turkish children with asthma or allergic rhinitis have a higher prevalence of PAI-1 4G allele compared with their healthy peers.


Asunto(s)
Asma/genética , Predisposición Genética a la Enfermedad , Inhibidor 1 de Activador Plasminogénico/genética , Polimorfismo Genético , Rinitis Alérgica Perenne/genética , Rinitis Alérgica Estacional/genética , Adolescente , Asma/epidemiología , Recuento de Células , Niño , Eosinófilos/inmunología , Eosinófilos/patología , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Inmunoglobulina E/sangre , Masculino , Inhibidor 1 de Activador Plasminogénico/inmunología , Inhibidor 1 de Activador Plasminogénico/metabolismo , Pruebas de Función Respiratoria , Rinitis Alérgica Perenne/epidemiología , Rinitis Alérgica Estacional/epidemiología , Pruebas Cutáneas , Turquía
9.
Pediatr Hematol Oncol ; 25(2): 99-106, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18363175

RESUMEN

Invasive fungal infection is one of the major causes of morbidity and mortality in immunocompromised patients. The occurrence of two invasive fungal infections in one patient at the same time is quite rare. Here the authors report on two adolescent patients with acute lymphoblastic leukemia who developed combined invasive pulmonary aspergillosis and hepatosplenic candidiasis during chemotherapy. They were treated with liposomal amphotericin B, but one of them died due to massive pulmonary hemorrhage during recovery from neutropenia.


Asunto(s)
Aspergilosis/etiología , Candidiasis/etiología , Hepatopatías/etiología , Enfermedades Pulmonares Fúngicas/etiología , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Enfermedades del Bazo/etiología , Tiflitis/etiología , Adolescente , Anfotericina B/administración & dosificación , Antifúngicos/administración & dosificación , Aspergilosis/diagnóstico por imagen , Aspergilosis/tratamiento farmacológico , Aspergilosis/microbiología , Candidiasis/diagnóstico por imagen , Candidiasis/tratamiento farmacológico , Candidiasis/microbiología , Candidiasis/patología , Resultado Fatal , Humanos , Huésped Inmunocomprometido , Hepatopatías/diagnóstico por imagen , Hepatopatías/tratamiento farmacológico , Hepatopatías/microbiología , Enfermedades Pulmonares Fúngicas/diagnóstico por imagen , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/microbiología , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico por imagen , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/microbiología , Radiografía , Enfermedades del Bazo/diagnóstico por imagen , Enfermedades del Bazo/tratamiento farmacológico , Enfermedades del Bazo/microbiología , Tiflitis/diagnóstico por imagen , Tiflitis/tratamiento farmacológico
10.
Indian J Pediatr ; 74(10): 950-2, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17978457

RESUMEN

Parvovirus-B19 has been reported a rare cause of acute laryngitis. Here, we described an 11-month-old girl who had prolonged acute laryngitis and neutropenia associated with parvovirus-B19 infection. Intravenous immunoglobulin therapy resulted in resolution of her symptoms, except neutropenia. We concluded that parvovirus-B19 can cause prolonged laryngitis and intravenous immunoglobulin treatment should be considered.


Asunto(s)
Laringitis/etiología , Neutropenia/etiología , Infecciones por Parvoviridae/diagnóstico , Parvovirus B19 Humano , Crup/diagnóstico , Crup/tratamiento farmacológico , Dexametasona/uso terapéutico , Diagnóstico Diferencial , Quimioterapia Combinada , Femenino , Humanos , Imipenem/uso terapéutico , Inmunización Pasiva , Lactante , Laringitis/diagnóstico , Laringitis/tratamiento farmacológico , Neutropenia/diagnóstico , Neutropenia/tratamiento farmacológico , Infecciones por Parvoviridae/tratamiento farmacológico
11.
Pediatr Pulmonol ; 42(12): 1187-92, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17960821

RESUMEN

Recent studies have emphasized the presence of airway hyperreactivity (AHR) in children with sickle cell disease (SCD). However, various tests for the detection of AHR have yielded distinctly different results in these patients. This study identified AHR via a methacholine challenge test (MCT) in a group of children with SCD (31 patients; age range, 6-16 years). The results of pulmonary function tests (PFTs) in patients with SCD and age-matched controls (30 healthy children) were investigated and compared. A positive methacholine challenge result was noted in 25 patients (77.5%). We found that when compared with controls, the children with SCD had lower forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV(1)) and that both their forced expiratory flow at 25-75% of the FVC (FEF(25-75)) and their FEV(1)/FVC ratio were not statistically significantly different from those of the controls. The statistically significant differences remained after treatment with a bronchodilator agent, but the changes in the FVC, FEV(1), and FEF(25-75) in response to bronchodilator treatment did not differ with statistical significance between the two groups. There was a negative correlation between the number of ACS attacks and the percent predicted of the FEV(1) and the FEV(1)/FVC ratio. We found that the MCT reveals a high incidence of AHR in patients with SCD, regardless of whether those individuals have ACS.


Asunto(s)
Anemia de Células Falciformes/complicaciones , Broncoconstrictores , Cloruro de Metacolina , Hipersensibilidad Respiratoria/diagnóstico , Administración por Inhalación , Adolescente , Pruebas de Provocación Bronquial/métodos , Broncoconstrictores/administración & dosificación , Niño , Femenino , Estudios de Seguimiento , Flujo Espiratorio Forzado/fisiología , Humanos , Masculino , Cloruro de Metacolina/administración & dosificación , Nebulizadores y Vaporizadores , Hipersensibilidad Respiratoria/etiología , Hipersensibilidad Respiratoria/fisiopatología , Índice de Severidad de la Enfermedad , Capacidad Vital/fisiología
12.
J Pediatr Endocrinol Metab ; 19(8): 1015-23, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16995587

RESUMEN

The aim of this study was to compare the results of low-dose (LDT) and standard-dose (SDT) ACTH tests in the assessment of adrenal function in 30 asthmatic children (mean age 9.35 +/- 1.9 years, 19 boys) who were treated with budesonide Turbohaler at conventional 400 microg or 600 microg daily doses for 8 weeks by a prospective, randomized, and open parallel study. Budesonide did not lead to any significant suppression of the hypothalamic-pituitary-adrenal (HPA) axis in either treatment group. However, when individual patient values were examined at the end point, peak cortisol concentrations after LDT were below 2 SDs of the pretreatment values in four patients (13.3%). Also, the increment in cortisol values was <200 nmol/l in all four patients. Decreased 24-hour urinary free cortisol excretion provided further evidence for HPA axis suppression in these patients. Two of these four poor responders to LDT showed normal stimulation with SDT. In conclusion, even with moderate doses and short-term use, adrenal suppression may occur in certain susceptible patients. The low-dose ACTH test is more reliable than SDT for the evaluation of such patients.


Asunto(s)
Hormona Adrenocorticotrópica , Asma/tratamiento farmacológico , Asma/fisiopatología , Budesonida/uso terapéutico , Glucocorticoides/uso terapéutico , Sistema Hipotálamo-Hipofisario/fisiología , Administración por Inhalación , Adolescente , Hormona Adrenocorticotrópica/administración & dosificación , Budesonida/administración & dosificación , Niño , Femenino , Glucocorticoides/administración & dosificación , Humanos , Hidrocortisona/orina , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Masculino , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA